期刊文献+

间充质干细胞免疫调节机制的研究新进展

Recent Research Progress in Immunomodulatory Mechanisms of Mesenchymal Stem Cells
下载PDF
导出
摘要 间充质干细胞(MSC)广泛存在于胎儿、成人骨髓、脂肪等不同组织中,是一种具有多向分化潜能的多能祖细胞,且具有广泛的免疫调节作用,在组织工程和免疫调节领域表现出极大的应用价值。MSC介导的免疫调节主要表现为免疫抑制,抑制细胞周期蛋白D2,发挥对各型免疫细胞非特异性的抗增殖及功能抑制效应。目前,对MSC免疫抑制的研究主要集中在吲哚胺-2,3-双加氧酶、地诺前列酮、一氧化氮等可溶性细胞因子以及调节性T细胞、T淋巴细胞、B淋巴细胞等靶细胞。现就MSC免疫调节机制的最新研究进展予以综述。 Mesenchymal stem cells(MSC)are a type of multipotent progenitor cell,isolated from the bone marrow,adipose tissue and various fetal and postnatal organs and tissues,with powerful immunomodulatory effects making MSC of great interest in tissue engineering and immunomodulatory.Underlying the MSC-mediated immunomodulatory mechanisms is a nonspecific immunosuppression effects,which include inhibition of proliferation and function of various immune cells,which is the consequence of cyclin D2 inhibition.At present,several studies have been conducted in the field of indoleamine 2,3-dioxygenase,prostaglandin E2,nitric oxide,and their target cells such as T regulatory cell,T cells,B cells.Here is to make a review on the recent research progress of the mechanisms of MSC-induced immunomodulation.
出处 《医学综述》 2012年第4期501-504,共4页 Medical Recapitulate
关键词 间充质干细胞 免疫抑制 可溶性细胞因子 靶细胞 Mesenchymal stem cells Immunosuppression Soluble cytokine Target cells
  • 相关文献

二级参考文献10

  • 1BrAsky RA, Jones RJ. Ap|astic anemia. Lancet, 2005,365 : 1647- 1656.
  • 2Bacigalupo A, Valle M, PAesto M, et ah T-cell suppression mediated by mesenehymal stem cells is deficient in patients with severe aplastic anemia. Exp Hemato1,2005 ,33 :819-827.
  • 3Chao YH,Peng CT,Harn HJ,et al. Poor potential of proliferation and differentiation in bone marrow mesenchymal stern cells derived from children with severe aplastic anemia. Ann Hematol, 2010, 89:715-723.
  • 4Li R, Wei F, Yu J, et al. IDO inhibits T-cell function through suppressing Vavl expression and activation. Cancer Bio| Tber, 2009,8 : 1402 - 1408.
  • 5Meisel R, Zbert A, Lat),ea M, et al. Human bone marrow stromal cells inhibit allogenic T-cell response by indoleamine 2, 3-dioxygenase mediated tl-yptophan degradation. BloA, 2004, 103: 4619-4621.
  • 6Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Diseiv, 2006,5:471 ~-84.
  • 7Chan JL,Tang KC, Patel AP, el al. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. BloA ,2006,107:4817-4824.
  • 8Beyth S, Borovsky Z, Mevorach D,et aL Human mesenchymal stem cells alter antigen-p resenting cell maturation and induce T-cell unresponsiveness. BloA ,2005,105:2214-2219.
  • 9Romani L, Bistoni F, Perruccio K, et al. Thymosin al activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. BloA, 2006,108:2265-2274.
  • 10中华医学会儿科学分会血液学组.小儿再生障碍性贫血的诊疗建议[J].中华儿科杂志,2001,39(7):422-423. 被引量:74

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部